Department of Psychiatry Archives
Sep. 30, 2021—A joint project between the Vanderbilt Kennedy Center and the Vanderbilt Center for Cognitive Medicine will help deliver Alzheimer’s disease therapies and treatments to people with Down syndrome (DS).
Aug. 5, 2021—The Department of Psychiatry and Behavioral Sciences has received an additional $4 million from the National Institute of Mental Health (NIMH) to study the evolution of hippocampal dysfunction in the early stage of psychosis.
Jul. 27, 2021—Mary Pawlikowski, MA, MEd, interim vice president and chief operating officer for Vanderbilt Psychiatric Hospital (VPH), has been named as the hospital’s new president after having held the position of president on an interim basis since November 2020.
Jul. 22, 2021—Leah Jesse, MD, a Psychiatry resident, successfully brought an anti-stigma resolution to the floor of the Tennessee Medical Association (TMA) House of Delegates meeting in May.
Webinars share strategies for integrating addiction and behavioral health into primary care practices
May. 12, 2021—David Marcovitz, MD, assistant professor of Psychiatry and Behavioral Sciences and director of the Division of Addiction Psychiatry, shared strategies for integrating addiction and behavioral health into primary care practices during two recent webinars — one for Vanderbilt Health Affiliated Network (VHAN) and one for the TennCare Delivery System Transformation Conference.
Apr. 29, 2021—For people with co-occurring mental health disorders and substance use disorders, finding integrated care that treats both conditions can be a difficult task. Vanderbilt Behavioral Health is seeking to simplify care for these patients through the co-occurring disorders intensive outpatient program (IOP).
Apr. 22, 2021—Older adults with depression face a unique obstacle — dealing with both a mental illness and the challenges that come along with aging. Currently, there are no treatments on the market targeting depression in this specific group.
Apr. 2, 2021—Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.
Feb. 18, 2021—On Friday, Feb. 5, the Department of Psychiatry and Behavioral Sciences hosted the third annual Harold Jordan Diversity and Inclusion Lecture featuring guest speaker Ruth Shim, MD, MPH, professor of Cultural Psychiatry and Clinical Psychiatry at the University of California, Davis.